Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -7.58% is 407% below its 5-year average of 2.47%, near the high end of its 5-year range (-77.80%–12.82%).
47.79% below its 12-month average of -5.13%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -18.09%.
NET PROFIT MARGIN
-7.58%
NET PROFIT MARGIN AVG TTM
-5.13%
NET PROFIT MARGIN AVG 3Y
-2.43%
NET PROFIT MARGIN AVG 5Y
2.47%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-47.79%
CURRENT VS 3Y AVG
-212.35%
CURRENT VS 5Y AVG
-407.13%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 758 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
AdaptHealth Corp.
Market Cap
$797.32M
Net Profit Margin
-7.58%
TTM Avg
-5.13%
3Y Avg
-2.43%
5Y Avg
2.47%
Market Cap
$795.49M
Net Profit Margin
-34.17%
TTM Avg
-136.69%
3Y Avg
-25443.25%
5Y Avg
-23332.75%
Market Cap
$793.58M
Net Profit Margin
-14.52%
TTM Avg
7.87%
3Y Avg
-15.98%
5Y Avg
-254.57%
Market Cap
$805.92M
Net Profit Margin
20.69%
TTM Avg
35.62%
3Y Avg
36.75%
5Y Avg
38.26%
Market Cap
$808.58M
Net Profit Margin
-12.35%
TTM Avg
-13.43%
3Y Avg
-52.20%
5Y Avg
-503.49%
Market Cap
$782.00M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$775.17M
Net Profit Margin
-147.38%
TTM Avg
-372.93%
3Y Avg
-22199.44%
5Y Avg
-19748.48%
Market Cap
$774.97M
Net Profit Margin
-4490.89%
TTM Avg
-2245.45%
3Y Avg
-2245.45%
5Y Avg
-2245.45%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AdaptHealth Corp. (AHCO) | $797.32M | -7.58% | -5.13% | -2.43% | 2.47% |
| Geron Corporation (GERN)vs › | $795.49M | -34.17% | -136.69% | -25443.25% | -23332.75% |
| Gyre Therapeutics, Inc. (GYRE)vs › | $793.58M | -14.52% | 7.87% | -15.98% | -254.57% |
| InMode Ltd. (INMD)vs › | $805.92M | 20.69% | 35.62% | 36.75% | 38.26% |
| Apnimed, Inc. (APMD)vs › | $788.50M | N/A | N/A | N/A | N/A |
| Ardelyx, Inc. (ARDX)vs › | $808.58M | -12.35% | -13.43% | -52.20% | -503.49% |
| Sana Biotechnology, Inc. (SANA)vs › | $782.00M | 0.00% | 0.00% | 0.00% | 0.00% |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $775.17M | -147.38% | -372.93% | -22199.44% | -19748.48% |
| Attovia Therapeutics, Inc. (ATTO)vs › | $774.97M | -4490.89% | -2245.45% | -2245.45% | -2245.45% |
| Jade Biosciences, Inc. (JBIO)vs › | $820.60M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
-0.3%
Net Profit Margin
-7.6%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -18.09% |
| 2026-04-10 | -1.96% |
| 2025-12-31 | -12.14% |
| 2025-09-30 | 4.07% |
| 2025-06-30 | 2.48% |
| 2025-03-31 | -1.24% |
| 2024-12-31 | 5.87% |
| 2024-09-30 | 3.83% |
| 2024-06-30 | 3.27% |
| 2024-03-31 | -0.36% |
| 2023-12-31 | -17.23% |
| 2023-09-30 | -77.80% |
| 2023-06-30 | 2.39% |
| 2023-03-31 | 2.11% |
| 2022-12-31 | -0.19% |
| 2022-09-30 | 2.89% |
| 2022-06-30 | 2.64% |
| 2022-03-31 | 7.96% |
| 2021-12-31 | 3.27% |
| 2021-09-30 | 12.29% |
| 2021-06-30 | 12.82% |
| 2021-03-31 | -0.82% |
| 2020-12-31 | -18.90% |
| 2020-09-30 | -17.94% |
| 2020-06-30 | 1.93% |
| 2020-03-31 | -18.05% |
| 2019-12-31 | -2.29% |
| 2019-09-30 | -0.11% |
| 2019-06-30 | -0.54% |
| 2019-03-31 | 0.69% |
| 2018-12-31 | 0.61% |
| 2018-09-30 | 0.51% |
| 2018-06-30 | 1.03% |
| 2018-03-31 | 0.33% |
